104 related articles for article (PubMed ID: 12949841)
1. Chemotherapeutic efficacy of topical celecoxib in a murine model of ultraviolet light B-induced skin cancer.
Wilgus TA; Koki AT; Zweifel BS; Rubal PA; Oberyszyn TM
Mol Carcinog; 2003 Sep; 38(1):33-9. PubMed ID: 12949841
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of cutaneous ultraviolet light B-mediated inflammation and tumor formation with topical celecoxib treatment.
Wilgus TA; Koki AT; Zweifel BS; Kusewitt DF; Rubal PA; Oberyszyn TM
Mol Carcinog; 2003 Oct; 38(2):49-58. PubMed ID: 14502644
[TBL] [Abstract][Full Text] [Related]
3. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis.
Fischer SM; Lo HH; Gordon GB; Seibert K; Kelloff G; Lubet RA; Conti CJ
Mol Carcinog; 1999 Aug; 25(4):231-40. PubMed ID: 10449029
[TBL] [Abstract][Full Text] [Related]
4. Vitamin E analog, alpha-tocopherol ether-linked acetic acid analog, alone and in combination with celecoxib, reduces multiplicity of ultraviolet-induced skin cancers in mice.
Riedel SB; Fischer SM; Sanders BG; Kline K
Anticancer Drugs; 2008 Feb; 19(2):175-81. PubMed ID: 18176114
[TBL] [Abstract][Full Text] [Related]
5. Chemopreventive activity of parthenolide against UVB-induced skin cancer and its mechanisms.
Won YK; Ong CN; Shi X; Shen HM
Carcinogenesis; 2004 Aug; 25(8):1449-58. PubMed ID: 15033901
[TBL] [Abstract][Full Text] [Related]
6. Treatment with 5-fluorouracil and celecoxib displays synergistic regression of ultraviolet light B-induced skin tumors.
Wilgus TA; Breza TS; Tober KL; Oberyszyn TM
J Invest Dermatol; 2004 Jun; 122(6):1488-94. PubMed ID: 15175041
[TBL] [Abstract][Full Text] [Related]
7. Topical treatment with OGG1 enzyme affects UVB-induced skin carcinogenesis.
Wulff BC; Schick JS; Thomas-Ahner JM; Kusewitt DF; Yarosh DB; Oberyszyn TM
Photochem Photobiol; 2008; 84(2):317-21. PubMed ID: 18086242
[TBL] [Abstract][Full Text] [Related]
8. Celecoxib inhibits phorbol ester-induced expression of COX-2 and activation of AP-1 and p38 MAP kinase in mouse skin.
Chun KS; Kim SH; Song YS; Surh YJ
Carcinogenesis; 2004 May; 25(5):713-22. PubMed ID: 14729583
[TBL] [Abstract][Full Text] [Related]
9. Reduction of UV-induced skin tumors in hairless mice by selective COX-2 inhibition.
Pentland AP; Schoggins JW; Scott GA; Khan KN; Han R
Carcinogenesis; 1999 Oct; 20(10):1939-44. PubMed ID: 10506108
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-1 deletion enhances apoptosis but does not protect against ultraviolet light-induced tumors.
Pentland AP; Scott G; VanBuskirk J; Tanck C; LaRossa G; Brouxhon S
Cancer Res; 2004 Aug; 64(16):5587-91. PubMed ID: 15313895
[TBL] [Abstract][Full Text] [Related]
11. Celecoxib and difluoromethylornithine in combination have strong therapeutic activity against UV-induced skin tumors in mice.
Fischer SM; Conti CJ; Viner J; Aldaz CM; Lubet RA
Carcinogenesis; 2003 May; 24(5):945-52. PubMed ID: 12771040
[TBL] [Abstract][Full Text] [Related]
12. Celecoxib reduces skin damage after radiation: selective reduction of chemokine and receptor mRNA expression in irradiated skin but not in irradiated mammary tumor.
Liang L; Hu D; Liu W; Williams JP; Okunieff P; Ding I
Am J Clin Oncol; 2003 Aug; 26(4):S114-21. PubMed ID: 12902868
[TBL] [Abstract][Full Text] [Related]
13. Combination of a poxvirus-based vaccine with a cyclooxygenase-2 inhibitor (celecoxib) elicits antitumor immunity and long-term survival in CEA.Tg/MIN mice.
Zeytin HE; Patel AC; Rogers CJ; Canter D; Hursting SD; Schlom J; Greiner JW
Cancer Res; 2004 May; 64(10):3668-78. PubMed ID: 15150127
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of cyclooxygenase-2 by celecoxib reverses tumor-induced wasting.
Davis TW; Zweifel BS; O'Neal JM; Heuvelman DM; Abegg AL; Hendrich TO; Masferrer JL
J Pharmacol Exp Ther; 2004 Mar; 308(3):929-34. PubMed ID: 14711936
[TBL] [Abstract][Full Text] [Related]
15. Effects of topical and oral vitamin E on pigmentation and skin cancer induced by ultraviolet irradiation in Skh:2 hairless mice.
Burke KE; Clive J; Combs GF; Commisso J; Keen CL; Nakamura RM
Nutr Cancer; 2000; 38(1):87-97. PubMed ID: 11341050
[TBL] [Abstract][Full Text] [Related]
16. Celecoxib modulates the expression of cyclooxygenase-2, ki67, apoptosis-related marker, and microvessel density in human cervical cancer: a pilot study.
Ferrandina G; Ranelletti FO; Legge F; Lauriola L; Salutari V; Gessi M; Testa AC; Werner U; Navarra P; Tringali G; Battaglia A; Scambia G
Clin Cancer Res; 2003 Oct; 9(12):4324-31. PubMed ID: 14555502
[TBL] [Abstract][Full Text] [Related]
17. Topical application of a selective cyclooxygenase inhibitor suppresses UVB mediated cutaneous inflammation.
Wilgus TA; Ross MS; Parrett ML; Oberyszyn TM
Prostaglandins Other Lipid Mediat; 2000 Oct; 62(4):367-84. PubMed ID: 11060900
[TBL] [Abstract][Full Text] [Related]
18. Dietary feeding of silibinin prevents early biomarkers of UVB radiation-induced carcinogenesis in SKH-1 hairless mouse epidermis.
Gu M; Dhanalakshmi S; Singh RP; Agarwal R
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1344-9. PubMed ID: 15894701
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase-2 inhibitor induces apoptosis in breast cancer cells in an in vivo model of spontaneous metastatic breast cancer.
Basu GD; Pathangey LB; Tinder TL; Lagioia M; Gendler SJ; Mukherjee P
Mol Cancer Res; 2004 Nov; 2(11):632-42. PubMed ID: 15561779
[TBL] [Abstract][Full Text] [Related]
20. Silibinin prevents ultraviolet radiation-caused skin damages in SKH-1 hairless mice via a decrease in thymine dimer positive cells and an up-regulation of p53-p21/Cip1 in epidermis.
Dhanalakshmi S; Mallikarjuna GU; Singh RP; Agarwal R
Carcinogenesis; 2004 Aug; 25(8):1459-65. PubMed ID: 15033902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]